CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease Conceptual Framework for Addressing Residual Atherosclerotic Cardiovascular Disease Risk in the Era of Precision Medicine One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial When, where, and how to target vascular inflammation in the post-CANTOS era? Ticagrelor With or Without Aspirin After Complex PCI Post-stenting fractional flow reserve vs coronary angiography for optimisation of percutaneous coronary intervention: TARGET-FFR trial Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk 'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial

Original Research2017 May;103(5):1544-1549.

JOURNAL:Ann Thorac Surg. Article Link

Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease

Müller J, Heck PB, Ewert P et al. Keywords: pulmonary hypertension; noninvasive screening; congenital heart disease; peak oxygen uptake

FULL TEXT PDF